Cập nhật thần kinh: COVID-19

Zhou M, Zhang X, Qu J (2020) Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. https://doi.org/10.1007/s11684-020-0767-8 Singh A, Zaheer S, Kumar N et al (2021) Covid19, beyond just the lungs: a review of multisystemic involvement by Covid19. Pathol Res Pract. https://doi.org/10.1016/j.prp.2021.153384 Mao L, Jin H, Wang M, et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. 8 Ameres M, Brandstetter S, Toncheva AA et al (2020) Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19. J Neurol. https://doi.org/10.1007/s00415-020-10050-y Virhammar J, Nääs A, Fällmar D et al (2020) Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity. Eur J Neurol. https://doi.org/10.1111/ene.14703 Kanberg N, Ashton NJ, Andersson L-M et al (2020) Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology 95:e1754–e1759. https://doi.org/10.1212/WNL.0000000000010111 RECOVERY Collaborative Group, Horby P, Lim WS et al (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384:693–704. https://doi.org/10.1056/NEJMoa2021436 Rezagholizadeh A, Khiali S, Sarbakhsh P, Entezari-Maleki T (2021) Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis. Eur J Pharmacol 897:173926. https://doi.org/10.1016/j.ejphar.2021.173926 Investigators REMAP-CAP, Gordon AC, Mouncey PR et al (2021) Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N Engl J Med 384(16):1491–1502. https://doi.org/10.1056/NEJMoa2100433 Nalbandian A, Sehgal K, Gupta A et al (2021) Post-acute COVID-19 syndrome. Nat Med 27:601–615. https://doi.org/10.1038/s41591-021-01283-z Gu J, Gong E, Zhang B et al (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202:415–424. https://doi.org/10.1084/jem.20050828 Lu R, Zhao X, Li J et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565–574. https://doi.org/10.1016/S0140-6736(20)30251-8 Li Y, Bai W, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 92(6):552–555. https://doi.org/10.1002/jmv.25728 Hamming I, Timens W, Bulthuis MLC et al (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631–637. https://doi.org/10.1002/path.1570 Song E, Zhang C, Israelow B et al (2021) Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. https://doi.org/10.1084/jem.20202135 Chen R, Wang K, Yu J et al (2021) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol. https://doi.org/10.3389/fneur.2020.573095 Brann DH, Tsukahara T, Weinreb C et al (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 6:eabc5801. https://doi.org/10.1126/sciadv.abc5801 Choi J-Y, Lee H-K, Park JH et al (2020) Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke. Biochem Biophys Res Commun 528:413–419. https://doi.org/10.1016/j.bbrc.2020.05.203 Mayi BS, Leibowitz JA, Woods AT et al (2021) The role of Neuropilin-1 in COVID-19. PLoS Pathog 17:e1009153. https://doi.org/10.1371/journal.ppat.1009153 Cantuti-Castelvetri L, Ojha R, Pedro LD et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370:856–860. https://doi.org/10.1126/science.abd2985 Raimondi C, Brash JT, Fantin A, Ruhrberg C (2016) NRP1 function and targeting in neurovascular development and eye disease. Prog Retin Eye Res 52:64–83. https://doi.org/10.1016/j.preteyeres.2016.02.003 Matschke J, Lütgehetmann M, Hagel C et al (2020) Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 19:919–929. https://doi.org/10.1016/S1474-4422(20)30308-2 Fabbri VP, Foschini MP, Lazzarotto T et al (2021) Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases. Brain Pathol 31:205–210. https://doi.org/10.1111/bpa.12901 Paniz-Mondolfi A, Bryce C, Grimes Z et al (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92:699–702. https://doi.org/10.1002/jmv.25915 Remmelink M, De Mendonça R, D’Haene N et al (2020) Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Crit Care. https://doi.org/10.1186/s13054-020-03218-5 Younger DS (2020) Postmortem neuropathology in Covid-19. Brain Pathol. https://doi.org/10.1111/bpa.12915 Kantonen J, Mahzabin S, Mäyränpää MI et al (2020) Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. https://doi.org/10.1111/bpa.12889 Schurink B, Roos E, Radonic T et al (2020) Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 1:e290–e299. https://doi.org/10.1016/S2666-5247(20)30144-0 Bryce C, Grimes Z, Pujadas E et al (2020) Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. medRxiv. https://doi.org/10.1101/2020.05.18.20099960 Lou JJ, Movassaghi M, Gordy D et al (2021) Neuropathology of COVID-19 (neuro-COVID): clinicopathological update. Free Neuropathol. https://doi.org/10.17879/freeneuropathology-2021-2993 Solomon IH, Normandin E, Bhattacharyya S et al (2020) Neuropathological features of Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMc2019373 Pajo AT, Espiritu AI, Apor ADAO, Jamora RDG (2021) Neuropathologic findings of patients with COVID-19: a systematic review. Neurol Sci. https://doi.org/10.1007/s10072-021-05068-7 Koyuncu OO, Hogue IB, Enquist LW (2013) Virus infections in the nervous system. Cell Host Microbe 13:379–393. https://doi.org/10.1016/j.chom.2013.03.010 Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11:995–998. https://doi.org/10.1021/acschemneuro.0c00122 Bodnar B, Patel K, Ho W et al (2021) Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19. J Med Virol 93:1983–1998. https://doi.org/10.1002/jmv.26720 Kacem I, Gharbi A, Harizi C et al (2021) Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19. Neurol Sci 42:39–46. https://doi.org/10.1007/s10072-020-04866-9 Gamage AM, Tan KS, Chan WOY et al (2020) Infection of human nasal epithelial cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles. PLoS Pathog 16:e1009130. https://doi.org/10.1371/journal.ppat.1009130 Hjalmarsson A, Blomqvist P, Brytting M et al (2009) Encephalitis after influenza in Sweden 1987–1998: a rare complication of a common infection. Eur Neurol 61:289–294. https://doi.org/10.1159/000206854 Cain MD, Salimi H, Diamond MS, Klein RS (2019) Mechanisms of pathogen invasion into the central nervous system. Neuron 103:771–783. https://doi.org/10.1016/j.neuron.2019.07.015 Taylor MP, Enquist LW (2015) Axonal spread of neuroinvasive viral infections. Trends Microbiol 23:283–288. https://doi.org/10.1016/j.tim.2015.01.002 DosSantos MF, Devalle S, Aran V et al (2020) Neuromechanisms of SARS-CoV-2: a review. Front Neuroanat. https://doi.org/10.3389/fnana.2020.00037 Keyhanian K, Umeton RP, Mohit B et al (2021) SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol 350:577436. https://doi.org/10.1016/j.jneuroim.2020.577436 Reza-Zaldívar EE, Hernández-Sapiéns MA, Minjarez B et al (2021) Infection mechanism of SARS-COV-2 and its implication on the nervous system. Front Immunol. https://doi.org/10.3389/fimmu.2020.621735 Engelhardt B, Vajkoczy P, Weller RO (2017) The movers and shapers in immune privilege of the CNS. Nat Immunol 18:123–131. https://doi.org/10.1038/ni.3666 Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-5 Fernández-Domínguez J, Ameijide-Sanluis E, García-Cabo C et al (2020) Miller–Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19). J Neurol 267:2495–2496. https://doi.org/10.1007/s00415-020-09912-2 Padroni M, Mastrangelo V, Asioli GM et al (2020) Guillain-Barré syndrome following COVID-19: new infection, old complication? J Neurol 267:1877–1879. https://doi.org/10.1007/s00415-020-09849-6 Llorente Ayuso L, Torres Rubio P, do Beijinho Rosário RF et al (2020) Bickerstaff encephalitis after COVID-19. J Neurol. https://doi.org/10.1007/s00415-020-10201-1 Pfefferkorn T, Dabitz R, von Wernitz-Keibel T et al (2020) Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19. J Neurol 267:1883–1884. https://doi.org/10.1007/s00415-020-09897-y Rifino N, Censori B, Agazzi E et al (2020) Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy. J Neurol. https://doi.org/10.1007/s00415-020-10251-5 Abu-Rumeileh S, Abdelhak A, Foschi M et al (2020) Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. https://doi.org/10.1007/s00415-020-10124-x Keddie S, Pakpoor J, Mousele C et al (2020) Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. https://doi.org/10.1093/brain/awaa433 Lucchese G, Flöel A (2020) SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. https://doi.org/10.1007/s12192-020-01145-6 Zachariadis A, Tulbu A, Strambo D et al (2020) Transverse myelitis related to COVID-19 infection. J Neurol 267:3459–3461. https://doi.org/10.1007/s00415-020-09997-9 Munz M, Wessendorf S, Koretsis G et al (2020) Acute transverse myelitis after COVID-19 pneumonia. J Neurol 267:2196–2197. https://doi.org/10.1007/s00415-020-09934-w Parsons T, Banks S, Bae C et al (2020) COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol 267:2799–2802. https://doi.org/10.1007/s00415-020-09951-9 Novi G, Rossi T, Pedemonte E et al (2020) Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. https://doi.org/10.1212/NXI.0000000000000797 Escobar M, Kataria S, Khan E et al (2021) Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: a case report and review of literature. J Neuroimmunol 353:577523. https://doi.org/10.1016/j.jneuroim.2021.577523 Poyiadji N, Shahin G, Noujaim D et al (2020) COVID-19–associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology 296:E119–E120. https://doi.org/10.1148/radiol.2020201187 Wang GF, Li W, Li K (2010) Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol 23:305–311. https://doi.org/10.1097/wco.0b013e328338f6c9 Ragab D, Salah Eldin H, Taeimah M et al (2020) The COVID-19 cytokine storm; what we know so far. Front Immunol 11:1446. https://doi.org/10.3389/fimmu.2020.01446 Zuhorn F, Omaimen H, Ruprecht B et al (2020) Parainfectious encephalitis in COVID-19: “The Claustrum Sign.” J Neurol. https://doi.org/10.1007/s00415-020-10185-y Nersesjan V, Amiri M, Lebech A-M et al (2021) Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up. J Neurol. https://doi.org/10.1007/s00415-020-10380-x Forestier G, de Beaurepaire I, Bornet G, Boulouis G (2020) Cytotoxic lesion of the corpus callosum as presenting neuroradiological manifestation of COVID-2019 infection. J Neurol. https://doi.org/10.1007/s00415-020-10166-1 Chaumont H, San-Galli A, Martino F et al (2020) Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection. J Neurol 267:3121–3127. https://doi.org/10.1007/s00415-020-09986-y Moreau A, Ego A, Vandergheynst F et al (2020) Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection. J Neurol. https://doi.org/10.1007/s00415-020-10164-3 Helms J, Kremer S, Merdji H et al (2020) Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit Care. https://doi.org/10.1186/s13054-020-03200-1 Lee DW, Santomasso BD, Locke FL et al (2019) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25:625–638. https://doi.org/10.1016/j.bbmt.2018.12.758 Pensato U, Muccioli L, Cani I et al (2021) Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy. Ann Clin Transl Neurol 8:968–979. https://doi.org/10.1002/acn3.51348 Huang X, Hussain B, Chang J (2020) Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms. CNS Neurosci Ther 27:36–47. https://doi.org/10.1111/cns.13569 Varatharaj A, Galea I (2017) The blood-brain barrier in systemic inflammation. Brain Behav Immun 60:1–12. https://doi.org/10.1016/j.bbi.2016.03.010 Perry VH, Holmes C (2014) Microglial priming in neurodegenerative disease. Nat Rev Neurol 10:217–224. https://doi.org/10.1038/nrneurol.2014.38 Yang T, Velagapudi R, Terrando N (2020) Neuroinflammation after surgery: from mechanisms to therapeutic targets. Nat Immunol 21:1319–1326. https://doi.org/10.1038/s41590-020-00812-1 Wilson JE, Mart MF, Cunningham C et al (2020) Delirium. Nat Rev Dis Primers 6:1–26. https://doi.org/10.1038/s41572-020-00223-4 von Weyhern CH, Kaufmann I, Neff F, Kremer M (2020) Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet 395:e109. https://doi.org/10.1016/S0140-6736(20)31282-4 Westhoff D, Engelen-Lee JY, Hoogland ICM et al (2019) Systemic infection and microglia activation: a prospective postmortem study in sepsis patients. Immun Ageing. https://doi.org/10.1186/s12979-019-0158-7 Mazeraud A, Righy C, Bouchereau E et al (2020) Septic-associated encephalopathy: a comprehensive review. Neurotherapeutics 17:392–403. https://doi.org/10.1007/s13311-020-00862-1 Sriwastava S, Tandon M, Kataria S et al (2020) New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol. https://doi.org/10.1007/s00415-020-10263-1 Assini A, Gandoglia I, Damato V et al (2021) Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection. Eur J Neurol. https://doi.org/10.1111/ene.14721 Ghosh R, De K, Roy D et al (2020) A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection. J Neuroimmunol 350:577439. https://doi.org/10.1016/j.jneuroim.2020.577439 Panariello A, Bassetti R, Radice A et al (2020) Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: a case report. Brain Behav Immun 87:179–181. https://doi.org/10.1016/j.bbi.2020.05.054 Merayo-Chalico J, Rajme-López S, Barrera-Vargas A et al (2016) Lymphopenia and autoimmunity: a double-edged sword. Hum Immunol 77:921–929. https://doi.org/10.1016/j.humimm.2016.06.016 Khosroshahi LM, Rezaei N (2020) Dysregulation of the immune response in COVID-19. Cell Biol Int. https://doi.org/10.1002/cbin.11517 Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147. https://doi.org/10.1016/j.thromres.2020.04.013 Helms J, Tacquard C, Severac F et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46:1089–1098. https://doi.org/10.1007/s00134-020-06062-x Merkler AE, Parikh NS, Mir S et al (2020) Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. jaMA Neurol 77:1366. https://doi.org/10.1001/jamaneurol.2020.2730 de Sousa DA, Sandset EC, Elkind MSV (2020) The curious case of the missing strokes during the covID-19 pandemic. Stroke 51:1921–1923. https://doi.org/10.1161/STROKEAHA.120.030792 Perry R, Banaras A, Werring DJ, Simister R (2020) What has caused the fall in stroke admissions during the COVID-19 pandemic? J Neurol 267:3457–3458. https://doi.org/10.1007/s00415-020-10030-2 Sierra-Hidalgo F, Muñoz-Rivas N, Torres Rubio P et al (2020) Large artery ischemic stroke in severe COVID-19. J Neurol 267:3441–3443. https://doi.org/10.1007/s00415-020-09967-1 Yaghi S, Ishida K, Torres J et al (2020) SARS2-CoV-2 and stroke in a New York healthcare system. Stroke. https://doi.org/10.1161/STROKEAHA.120.030335 Tsivgoulis G, Palaiodimou L, Zand R et al (2020) COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord. https://doi.org/10.1177/1756286420978004 Bang OY, Lee MJ, Ryoo S et al (2015) Patent foramen ovale and stroke-current status. J Stroke 17:229–237. https://doi.org/10.5853/jos.2015.17.3.229 Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 191:148–150. https://doi.org/10.1016/j.thromres.2020.04.041 Beyrouti R, Adams ME, Benjamin L et al (2020) Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 91:889–891. https://doi.org/10.1136/jnnp-2020-323586 Tung ML, Tan B, Cherian R, Chandra B (2021) Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract. https://doi.org/10.1093/rap/rkaa081 Goshua G, Pine AB, Meizlish ML et al (2020) Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 7:e575–e582. https://doi.org/10.1016/S2352-3026(20)30216-7 Ferrario CM, Jessup J, Chappell MC et al (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111:2605–2610. https://doi.org/10.1161/CIRCULATIONAHA.104.510461 Calabretta E, Moraleda JM, Iacobelli M et al (2021) COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies. Br J Haematol. 193(1):43–51https://doi.org/10.1111/bjh.17240 Ackermann M, Verleden SE, Kuehnel M et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383:120–128. https://doi.org/10.1056/NEJMoa2015432 Conklin J, Frosch MP, Mukerji SS et al (2021) Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19. J Neurol Sci 421:117308. https://doi.org/10.1016/j.jns.2021.117308 Edlow BL, Claassen J, Victor JD et al (2020) Delayed reemergence of consciousness in survivors of severe COVID-19. Neurocrit Care 33:627–629. https://doi.org/10.1007/s12028-020-01133-9 Cani I, Barone V, D’Angelo R et al (2021) Frontal encephalopathy related to hyperinflammation in COVID-19. J Neurol 268:16–19. https://doi.org/10.1007/s00415-020-10057-5 Chan JL, Murphy KA, Sarna JR (2021) Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J Neurol. https://doi.org/10.1007/s00415-021-10458-0 Lersy F, Willaume T, Brisset J-C et al (2020) Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses. J Neurol. https://doi.org/10.1007/s00415-020-10313-8 Choi Y, Lee MK (2020) Neuroimaging findings of brain MRI and CT in patients with COVID-19: a systematic review and meta-analysis. Eur J Radiol 133:109393. https://doi.org/10.1016/j.ejrad.2020.109393 Kirschenbaum D, Imbach LL, Rushing EJ et al (2020) Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathol Appl Neurobiol. https://doi.org/10.1111/nan.12677 Vinci R, Pedicino D, Andreotti F et al (2021) From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: a paradigm drawn from COVID-19. Int J Cardiol 326:243–247. https://doi.org/10.1016/j.ijcard.2020.11.016 Needham E, Newcombe V, Michell A et al (2020) Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19. J Neurol. https://doi.org/10.1007/s00415-020-10321-8 Fanou EM, Coutinho JM, Shannon P et al (2017) Critical illness-associated cerebral microbleeds. Stroke 48:1085–1087. https://doi.org/10.1161/STROKEAHA.116.016289 Riech S, Kallenberg K, Moerer O et al (2015) The pattern of brain microhemorrhages after severe lung failure resembles the one seen in high-altitude cerebral edema. Crit Care Med 43:e386-389. https://doi.org/10.1097/CCM.0000000000001150 Burkhard-Koren NM, Haberecker M, Maccio U et al (2021) Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from ‘Spanish flu’ 1918/1919 in Switzerland to Coronavirus disease 2019. J Pathol Clin Res 7:135–143. https://doi.org/10.1002/cjp2.189 Brummel NE, Girard TD (2019) Delirium in the critically ill patient. Handb Clin Neurol 167:357–375. https://doi.org/10.1016/B978-0-12-804766-8.00019-4 Ammar MA, Sacha GL, Welch SC et al (2021) Sedation, analgesia, and paralysis in COVID-19 patients in the setting of drug shortages. J Intensive Care Med 36:157–174. https://doi.org/10.1177/0885066620951426 Müller A, von Hofen-Hohloch J, Mende M et al (2020) Long-term cognitive impairment after ICU treatment: a prospective longitudinal cohort study (Cog-I-CU). Sci Rep. https://doi.org/10.1038/s41598-020-72109-0 Antony AR, Haneef Z (2020) Systematic review of EEG findings in 617 patients diagnosed with COVID-19. Seizure 83:234–241. https://doi.org/10.1016/j.seizure.2020.10.014 Miller C, O’Sullivan J, Jeffrey J, Power D (2021) Brachial plexus neuropathies during the COVID-19 pandemic: a retrospective case series of 15 patients in critical care. Phys Ther. https://doi.org/10.1093/ptj/pzaa191 Malik GR, Wolfe AR, Soriano R et al (2020) Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome. Br J Anaesth 125:e478–e480. https://doi.org/10.1016/j.bja.2020.08.045 Bednarík J, Vondracek P, Dusek L et al (2005) Risk factors for critical illnesspolyneuromyopathy. J Neurol 252:343–351. https://doi.org/10.1007/s00415-005-0654-x Frithiof R, Rostami E, Kumlien E et al (2020) Critical illness polyneuropathy and myopathy in COVID-19 patients: a prospective observational intensive care unit cross-sectional cohort study. https://doi.org/10.21203/rs.3.rs-78038/v1, https://www.researchsquare.com. Accessed 2 Mar 2021 (Preprint) Nasr DM, Rabinstein AA (2015) Neurologic complications of extracorporeal membrane oxygenation. J Clin Neurol 11:383–389. https://doi.org/10.3988/jcn.2015.11.4.383 Notz Q, Lotz C, Herrmann J et al (2020) Severe neurological complications in critically ill COVID-19 patients. J Neurol. https://doi.org/10.1007/s00415-020-10152-7